NP and molecular docking studies revealed that Ailanthone extract exhibited potent inhibitory effects on colorectal cancer cells, particularly by promoting apoptosis. It effectively suppressed cancer cell viability and migration, regulated key pathways such as STAT3 and PI3K-Akt, and induced apoptosis, showcasing its potential in cancer therapy. The gene discussed is AKT1; the disease is cancer.